Astellas Pharma US President Mark Reisenauer recently joined PhRMA Senior Vice President of State Advocacy Scott LaGanga for a conversation about a range of topics that are important to patients...

Astellas is proud to share recent top leadership promotions and appointments across our divisions for employees based in the US. These leaders are all crucial in driving forward the company’s...

By Mark Reisenauer, President, Astellas Pharma US In February, STAT News held a virtual event, “The Exhaustion Epidemic: Examining the COVID-19 Burnout Crisis in Health Care,” that delved into...

In our ongoing commitment to better serve patients through development of innovative therapies that address unmet needs, Astellas is proud to share recent top leadership appointments across our...

The article below, co-authored by Mark Reisenauer, president of Astellas Pharma US, Tim Walbert, chairman, president and CEO of Horizon Therapeutics, and Peter Anastasiou, executive vice president...

Astellas Pharma Inc. announced changes in its Global Commercial Leadership Team reporting to Chief Commercial Officer Yukio Matsui aligned with the focuses for the new Corporate Strategic Plan 2021 (CSP2021).

Astellas is at an inflection point in our evolution, facing opportunities presented by our growing pipeline, but amidst a rapidly changing environment that is transforming the ways every segment...

To further our mission to meet patients’ unmet medical needs through innovative pharmaceutical products, we recently announced several strategic executive promotions in the Quality Assurance...

Nov 29, 2016 When Astellas’ President of Global Development, Dr. Bernie Zeiher, was in medical school, his mother succumbed to pancreatic cancer – a disease that afflicts tens of thousands of...